Overview

These guidelines provide recommendations on the diagnosis and management of type 2 diabetes and the management of asthma and chronic obstructive pulmonary disease in primary health care in low-resource settings. The target users are health care professionals responsible for developing the protocols which will be used by health care staff in primary care units in low-resource settings.

Contents

• Acknowledgments
• Why do we need these guidelines?
• I. Diagnosis and management of type 2 diabetes in primary health care in low-resource settings
  • Abbreviations
  • 1. Executive Summary
  • 2. Background
  • 3. Objectives and target audience
  • 4. Funding and declarations of interest
  • 5. Methodology and process
    • Scope of the guideline
  • 6. Adaptation and implementation
  • 7. Update
  • 8. Format and dissemination
  • 9. Impact and quality of the guideline
  • 10. Recommendations and evidence
    • A Diagnosing diabetes
    • B Glycaemic control
    • C Reducing the risk of cardiovascular disease and diabetic nephropathy
    • D Prevention of lower limb amputations
    • E Prevention of blindness
    • F Severe hypoglycaemia
    • G Hyperglycaemic emergencies
  • Reference List
  • Annex 1 Systematic reviews and GRADE tables
  • Annex 2 Benefits and harms of recommendations
  • Members of the guideline development group
• II. Management of Asthma and Chronic Obstructive Pulmonary Disease in primary health care in low-resource settings
  • Abbreviations
  • 1. Executive summary
  • 2. Recommendations
    • Management of stable asthma
    • Management of exacerbation of asthma
    • Management of stable COPD
    • Management of exacerbation of COPD
  • 3. Methodology used to prepare the guideline
    • Identification of important outcomes
    • Search strategy, selection criteria, data collection and judgement
  • Annex 3 PICOT questions
  • Annex 4 Grade tables
  • Annex 5 Search strategies
  • Annex 6 References (systematic reviews)
  • Annex 7 Summary of recommendations
  • Members of the Guideline Development Committee
• Simplified tools for implementation of the guidelines
• Other WHO documents on Prevention and Control of Noncommunicable Diseases

The designations employed and the presentation of the material in this publication do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement.

The mention of specific companies or of certain manufacturers' products does not imply that they are endorsed or recommended by the World Health Organization in preference to others of a similar nature that are not mentioned. Errors and omissions excepted, the names of proprietary products are distinguished by initial capital letters.

All reasonable precautions have been taken by the World Health Organization to verify the information contained in this publication. However, the published material is being distributed without warranty of any kind, either expressed or implied. The responsibility for the interpretation and use of the material lies with the reader. In no event shall the World Health Organization be liable for damages arising from its use.